Skip to Content
Merck
  • Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses.

Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra viruses.

Cell (2022-06-24)
Lay Teng Ang, Alana T Nguyen, Kevin J Liu, Angela Chen, Xiaochen Xiong, Matthew Curtis, Renata M Martin, Brian C Raftry, Chun Yi Ng, Uwe Vogel, Angelika Lander, Benjamin J Lesch, Jonas L Fowler, Alyssa R Holman, Timothy Chai, Siva Vijayakumar, Fabian P Suchy, Toshinobu Nishimura, Joydeep Bhadury, Matthew H Porteus, Hiromitsu Nakauchi, Christine Cheung, Steven C George, Kristy Red-Horse, Joseph B Prescott, Kyle M Loh
ABSTRACT

Stem cell research endeavors to generate specific subtypes of classically defined "cell types." Here, we generate >90% pure human artery or vein endothelial cells from pluripotent stem cells within 3-4 days. We specified artery cells by inhibiting vein-specifying signals and vice versa. These cells modeled viral infection of human vasculature by Nipah and Hendra viruses, which are extraordinarily deadly (∼57%-59% fatality rate) and require biosafety-level-4 containment. Generating pure populations of artery and vein cells highlighted that Nipah and Hendra viruses preferentially infected arteries; arteries expressed higher levels of their viral-entry receptor. Virally infected artery cells fused into syncytia containing up to 23 nuclei, which rapidly died. Despite infecting arteries and occupying ∼6%-17% of their transcriptome, Nipah and Hendra largely eluded innate immune detection, minimally eliciting interferon signaling. We thus efficiently generate artery and vein cells, introduce stem-cell-based toolkits for biosafety-level-4 virology, and explore the arterial tropism and cellular effects of Nipah and Hendra viruses.